St. Luke’s unveils state-of-the-art Center for Structural Heart and Vascular Interventions

St. Luke’s Medical Center is proud to announce the grand opening of its Center for Structural Heart and Vascular Interventions. This cutting-edge facility is designed to pioneer the expansion of minimally invasive options of care for patients with complex heart and vascular diseases. It is also envisioned as a center for advanced training and research on structural heart and vascular diseases, emphasizing the use of expanded multidisciplinary teams of care and quality-controlled environments to ensure exceptional outcomes of care. 

[From left to right: Dr. Dennis P. Serrano, St. Luke’s President and CEO; Mrs. Lenora A. Cabili, St. Luke’s Board Member; Atty. Cirilo P. Noel, St. Luke’s 1st Vice Chairman; Mr. Amando M. Tetangco, Jr., St. Luke’s Board Member; Dr. Fabio Enrique Posas, Head of St. Luke’s Center for Structural Heart and Vascular Interventions; Dr. Maria Adelaida M. Iboleon-Dy, Head of St. Luke’s Heart Institute; Dr. Anthony R. Perez, St. Luke’s Global City Assistant Chief Medical Officer]

The St. Luke’s Center for Structural Heart and Vascular Interventions represents a significant milestone in cardiac healthcare in the country. It combines advanced technology, hybrid operating theaters, and optimized imaging systems with pioneering and experienced teams of care. The center aims to expand minimally invasive options of care for patients with complex cardiovascular diseases who either are at high risk or who do not desire standard open-heart surgical interventions. All these are done while prioritizing individual patient needs under quality-controlled and monitored environments of care designed to optimize procedural outcomes. 

Led by Dr Fabio Enrique Posas, the country’s pioneer in transcatheter valve replacement and endovascular aortic aneurysm repair procedures, the center offers a wide range of innovative diagnostic and minimally invasive treatment modalities. It is designed to address complex, life-threatening cardiovascular diseases in patients who otherwise may have limited options of care or who face daunting open surgical procedures. Patients are expected to benefit from state-of-the-art imaging techniques and minimally invasive catheter and surgical interventions tailored to their specific conditions and risk profiles. 

“At St. Luke’s Medical Center, we are committed to providing the highest level of care for patients with complex structural heart and vascular diseases,” said Dr. Posas. “Our new Center for Structural Heart and Vascular Interventions (CSVI) is equipped with the latest technology, and is staffed by a multidisciplinary team of experts who are passionate about delivering personalized, minimally invasive care to our patients.” This team offers coordinated treatment plans tailored to each patient’s unique needs through collaboration and a shared commitment to advancing cardiovascular medicine. 

The center’s comprehensive service offerings include Transcatheter Aortic Valve Replacement (TAVR), a groundbreaking minimally invasive procedure for treating aortic valve stenosis that can be performed without general anesthesia or surgical cuts. In addition, our team of specialists has pioneered the use of trans-catheter mitral valve repair (Mitra Clip) for leaking mitral valves, and it is expected to expand options for trans-catheter mitral valve replacement and tricuspid valve replacement as well as repairs. Other advanced catheter-based interventions involve endovascular repair for aortic aneurysms and aortic dissections and hybrid surgical and vascular repairs for patients at extreme risk for standard surgical repairs. Such strategies are associated with faster recovery times, lower procedural complications, and mortality. 

With its quality-controlled environment of care and its comprehensive databases documenting outcomes of care and training programs, our medical center and our multidisciplinary teams of care are not only pioneering minimally invasive interventions in the country but are also considered one of the most advanced and pioneering centers for TAVR in Southeast Asia. With the formal launch of the center, the CSHVI is also celebrating another milestone, as it reaches 252 TAVR cases as of December 2023, solidifying its position as a leader in the field of structural heart interventions. Patients can expect exceptional clinical outcomes backed by the hospital’s commitment to precision, innovation, and excellence.

To know more about this new Center, patients may contact St. Luke’s Product Information Hub at 0919-057-7744 (call), 0919-160-7744 (text), or email [email protected].

ADVT.